Many gastrointestinal motility disorders arise due to defects in the enteric nervous system. Achalasia and gastroparesis are two extremely debilitating digestive diseases of the upper gastrointestinal tract caused in part by damage or loss of the nitrergic neurons in the esophagus and stomach. Most current pharmacological and surgical interventions provide no long-term relief from symptoms, and none address the cause. Stem cell therapy, to replace the missing neurons and restore normal gut motility, is an attractive alternative therapy. However, there are a number of hurdles that must be overcome to bring this exciting research from the bench to the bedside.
CITATION STYLE
Gardner-Russell, J., Kuriakose, J., Hao, M. M., & Stamp, L. A. (2022). Upper Gastrointestinal Motility, Disease and Potential of Stem Cell Therapy. In Advances in Experimental Medicine and Biology (Vol. 1383, pp. 319–328). Springer. https://doi.org/10.1007/978-3-031-05843-1_29
Mendeley helps you to discover research relevant for your work.